ASX - By Stock
|
MCT |
Re:
Ann: Quarterly Activities Report
|
|
volvoman
|
45 |
15K |
11 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
45
|
15K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
volvoman
|
116 |
43K |
2 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
116
|
43K
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
volvoman
|
82K |
49M |
5 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
82K
|
49M
|
5
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
volvoman
|
82K |
49M |
8 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
82K
|
49M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB - 1 step closer, 2 steps back
|
|
volvoman
|
17 |
6.1K |
13 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
17
|
6.1K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Onward
|
|
volvoman
|
27 |
10K |
12 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
27
|
10K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
volvoman
|
1.0K |
399K |
18 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
volvoman
|
1.0K |
399K |
12 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
volvoman
|
1.0K |
399K |
4 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
volvoman
|
1.0K |
399K |
20 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
volvoman
|
1.3K |
554K |
14 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
554K
|
14
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
volvoman
|
82K |
49M |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
82K
|
49M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
volvoman
|
1.3K |
554K |
37 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
554K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
volvoman
|
3.4K |
1.2M |
14 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
volvoman
|
3.4K |
1.2M |
55 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
55
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
volvoman
|
218 |
51K |
7 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
218
|
51K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
volvoman
|
218 |
51K |
5 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
218
|
51K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
volvoman
|
3.4K |
1.2M |
4 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
volvoman
|
3.4K |
1.2M |
26 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
26
|
|
ASX - By Stock
|
AVZ |
Re:
Links - DRC & Africa
|
|
volvoman
|
508 |
238K |
0 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
508
|
238K
|
0
|
|
ASX - By Stock
|
CLA |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
volvoman
|
3 |
1.5K |
9 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
3
|
1.5K
|
9
|
|
ASX - By Stock
|
CLA |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
volvoman
|
3 |
1.5K |
4 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
3
|
1.5K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
volvoman
|
3.4K |
1.2M |
0 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
volvoman
|
3.4K |
1.2M |
1 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Price
|
|
volvoman
|
37 |
14K |
1 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
37
|
14K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Price
|
|
volvoman
|
37 |
14K |
0 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
37
|
14K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Price
|
|
volvoman
|
37 |
14K |
8 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
37
|
14K
|
8
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Multiple New Priority Exploration Targets Identified
|
|
volvoman
|
43 |
23K |
4 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
43
|
23K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
volvoman
|
200 |
43K |
13 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
200
|
43K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
9.9K |
2.9M |
4 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
9.9K
|
2.9M
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
volvoman
|
200 |
43K |
8 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
200
|
43K
|
8
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Continuation of TIA
|
|
volvoman
|
168 |
92K |
2 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
168
|
92K
|
2
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Multiple New Priority Exploration Targets Identified
|
|
volvoman
|
43 |
23K |
13 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
43
|
23K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
volvoman
|
396 |
85K |
14 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
85K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
volvoman
|
396 |
85K |
22 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
85K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
volvoman
|
3.4K |
1.2M |
8 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
8
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Retraction of ASX Release
|
|
volvoman
|
10 |
3.5K |
1 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
10
|
3.5K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
9.9K |
2.9M |
17 |
25/06/23 |
25/06/23 |
ASX - By Stock
|
9.9K
|
2.9M
|
17
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Latest Patient Group Show Best Results to Date at 30 Days
|
|
volvoman
|
107 |
36K |
6 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
107
|
36K
|
6
|
|
ASX - By Stock
|
RNU Graphite |
Re:
General Discussions
|
|
volvoman
|
30K |
15M |
4 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
30K
|
15M
|
4
|
|
ASX - By Stock
|
1MC |
Re:
Ann: Drilling underway at Mallina Lithium
|
|
volvoman
|
48 |
21K |
5 |
11/06/23 |
11/06/23 |
ASX - By Stock
|
48
|
21K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust MND Trial Interim Analysis PK Outcomes
|
|
volvoman
|
105 |
27K |
4 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
105
|
27K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
43K |
21M |
2 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
43K
|
21M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
volvoman
|
362 |
114K |
9 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
362
|
114K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
volvoman
|
362 |
114K |
8 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
362
|
114K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
volvoman
|
1.0K |
392K |
3 |
21/05/23 |
21/05/23 |
ASX - By Stock
|
1.0K
|
392K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
volvoman
|
1.0K |
392K |
17 |
21/05/23 |
21/05/23 |
ASX - By Stock
|
1.0K
|
392K
|
17
|
|
ASX - By Stock
|
CLA |
Re:
Ann: CLA Signs Non-Binding Term Sheet and Subscription Agreement
|
|
volvoman
|
255 |
73K |
2 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
255
|
73K
|
2
|
|
ASX - By Stock
|
CLA |
Re:
Ann: CLA Signs Non-Binding Term Sheet and Subscription Agreement
|
|
volvoman
|
255 |
73K |
6 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
255
|
73K
|
6
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Receipt of Request for Joint ICC Arbitration Proceedings
|
|
volvoman
|
147 |
103K |
23 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
147
|
103K
|
23
|
|